Evidence map›Paper›PMID 37263680›Full record

ArticleBMJ case reports2023

Acute myopericarditis and left shoulder capsulitis following second dose of mRNA SARS-CoV-2 Moderna vaccination.

Adrien Quinodoz, Francois Luthi, Sylvie Revaz, Michel Konzelmann

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Adrien QuinodozDepartment of Musculoskeletal Rehabilitation, Clinique Romande de réadaptation, Sion, Switzerland quinodoza@gmail.com.
Francois LuthiDepartment of Musculoskeletal Rehabilitation, Clinique Romande de réadaptation, Sion, Switzerland.
Sylvie RevazAssessment and consultation service, Clinique Romande de réadaptation, Sion, Switzerland.
Michel KonzelmannAssessment and consultation service, Clinique Romande de réadaptation, Sion, Switzerland.
Clinique Romande de Réadaptation · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination against mRNA SARS-CoV-2 has been administered on a very large scale and various side effects have been described. The increased risk of myopericarditis is known, and only a few cases of shoulder capsulitis have been reported after vaccination. These two pathologies have never been reported in the same patient after vaccination. Our article presents the history of a man in his 40s who presented with myopericarditis a few days after vaccination against SARS-CoV-2 with mRNA(Messenger RNA) Moderna® vaccine and who at the same time developed shoulder capsulitis. His cardiovascular symptoms resolved rapidly, and his shoulder symptoms improved/resolved within 1 year. This case should make physicians aware of the possibility of several concomitant side effects following vaccination against SARS-CoV-2.

Indexed as

BursitisCOVID-19Drug-Related Side Effects and Adverse ReactionsMyocarditisPericarditisHumansMaleRNA, MessengerSARS-CoV-2ShoulderVaccinationRNA, MessengerCOVID-19Musculoskeletal and joint disordersRehabilitation medicineStiff shoulderVaccination/immunisation

Identifiers

PMID37263680
PMCPMC10254694
OpenAlexW4378980826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.